chr9-6241704-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_033439.4(IL33):āc.10A>Gā(p.Lys4Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000504 in 1,605,686 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_033439.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IL33 | NM_033439.4 | c.10A>G | p.Lys4Glu | missense_variant | 2/8 | ENST00000682010.1 | |
LOC107987046 | XR_001746614.2 | n.153-13409T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IL33 | ENST00000682010.1 | c.10A>G | p.Lys4Glu | missense_variant | 2/8 | NM_033439.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000445 AC: 11AN: 246960Hom.: 0 AF XY: 0.0000674 AC XY: 9AN XY: 133504
GnomAD4 exome AF: 0.0000544 AC: 79AN: 1453438Hom.: 1 Cov.: 28 AF XY: 0.0000484 AC XY: 35AN XY: 723052
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2022 | The c.10A>G (p.K4E) alteration is located in exon 2 (coding exon 1) of the IL33 gene. This alteration results from a A to G substitution at nucleotide position 10, causing the lysine (K) at amino acid position 4 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at